Piper Jaffray Maintains Overweight on Cutera (CUTR)

Piper Jaffray is out with its report today on Cutera CUTR, maintaining Overweight. In a note to clients, Piper Jaffray writes, "CUTR's miss on revenues drove a greater loss per share than expected. Inability to ship through Japan's customs due to the disaster was responsible for about $1M of the $2M miss. The remainder of the revenue "miss" (there had been no guidance) was from a slowdown in demand from European distributors and disruption in the North American sales force due to a strategic upgrade process. We expect Q1 was a low watermark for the year; with sales stability plus two new product launches, we continue to rate CUTR at Overweight with a $12/share price target." Shares of CUTR closed Monday at $8.88, up 0.45% from Friday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingscuteraHealth CareHealth Care EquipmentPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!